The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…

Novartis

Novartis' Lucentis combo flop gives Regeneron a shot at the wet AMD lead

Supreme Court urged to weigh in on six-month biosimilar delays

Ex-VP sues Bayer, saying she defended a pregnant colleague and got whacked for it

Roche's Gazyva aims to beat blockbuster Rituxan. Can its latest ASH data help?

AstraZeneca to shuffle off U.K. finance jobs as part of $1.1B cost-cutting scheme

Are DTC ads tipping the balance in psoriasis battle between Lilly’s Taltz and Novartis’ Cosentyx?